Pharmacotherapy of Vasospastic Angina.

Harris, Justin R; Hale, Genevieve M; Dasari, Tarun W; Schwier, Nicholas C

Harris, Justin R; Hale, Genevieve M; Dasari, Tarun W; Schwier, Nicholas C.

Affiliation

Harris JR; Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Hale GM; Department of Pharmacy Practice, Nova Southeastern University, Fort Lauderdale, FL, USA.
Dasari TW; Cardiovascular Section, University of Oklahoma College of Medicine, Oklahoma City, OK, USA.
Schwier NC; Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA nicholas-schwier@ouhsc.edu.

J Cardiovasc Pharmacol Ther ; 21(5): 439-51, 2016 09.

Article in En | MEDLINE | ID: mdl-27081186

Subject(s)

Angina Pectoris, Variant/drug therapy; Coronary Vasospasm/drug therapy; Coronary Vessels/drug effects; Vasoconstriction/drug effects; Vasodilator Agents/therapeutic use; Adrenergic alpha-1 Receptor Antagonists/therapeutic use; Angina Pectoris, Variant/diagnosis; Angina Pectoris, Variant/etiology; Angina Pectoris, Variant/physiopathology; Animals; Calcium Channel Blockers/therapeutic use; Coronary Vasospasm/diagnosis; Coronary Vasospasm/etiology; Coronary Vasospasm/physiopathology; Coronary Vessels/physiopathology; Humans; Nitrates/therapeutic use; Risk Factors; Treatment Outcome; Vasodilator Agents/adverse effects

Key words

calcium channel blockers; long-acting nitrates; vasospasm; vasospastic (Prinzmetal's) angina

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Vasoconstriction / Vasodilator Agents / Coronary Vasospasm / Coronary Vessels / Angina Pectoris, Variant Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google